Sign up to save your podcasts
Or
Share Ep 25. How does symptom duration before DMARD therapy impact the costs of RA?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ep 25. How does symptom duration before DMARD therapy impact the costs of RA?
Dr Ilfita Sahbudin (University of Birmingham, UK) joins Dr Ai Lyn Tan to discuss the relationship between symptom/disease duration and resource utilisation/costs following rheumatoid arthritis diagnosis.
Want to read the full paper? Find it here.
Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.
View all episodes
By British Society for Rheumatology
5
11 ratings
Dr Ilfita Sahbudin (University of Birmingham, UK) joins Dr Ai Lyn Tan to discuss the relationship between symptom/disease duration and resource utilisation/costs following rheumatoid arthritis diagnosis.
Want to read the full paper? Find it here.
Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.
More shows like Talking Rheumatology Research
View all
Rheumnow Podcast
124 Listeners
The Evidence Based Rheumatology Podcast
114 Listeners
ACR on Air
72 Listeners
The Rest Is History
13,448 Listeners
The Rest Is Politics
3,103 Listeners
Talking Rheumatology Spotlight
6 Listeners
ACR Journals On Air
20 Listeners